提高在年轻成年人群中诊断2型糖尿病的公平性和准确性
IEEE journal of biomedical and health informatics
|October 1, 2025
概括
机器学习模型在诊断糖尿病时经常忽略年轻人. 这项研究引入了针对年龄的个性化模型,在年轻人群体中显著改善了糖尿病检测回忆,高达40%.
科学领域:
- 医疗信息学 医疗信息学
- 机器学习 机器学习
- 公共卫生 公共卫生
背景情况:
- 2型糖尿病越来越多地在年轻人中被诊断出来,这一人口群体在历史上被认为是糖尿病人群中的少数群体.
- 现有的机器学习 (ML) 模型对少数群体 (包括年轻人) 存在偏见,可能会导致错误诊断导致不良健康结果.
- 以前的研究集中在减轻性别和种族的偏见,但没有有效地解决糖尿病预测中年轻年龄组的诊断差异.
研究的目的:
- 识别和解决传统ML模型中导致"数字年龄主义"和年轻成年人糖尿病低诊断的缺陷.
- 提出和评估一种算法,以减轻糖尿病预测中对年轻成年人群的偏见.
- 开发针对年龄的个性化ML模型,以提高年轻人群中糖尿病诊断的准确性.
主要方法:
- 开发了一个管道,为特定年龄段培养定制的ML模型,每个5岁年龄段都有单独的模型 (例如30-34,35-39,40-44).
- 这种方法偏离了"一个模型适合所有"的范式,通过创建特定年龄的诊断工具.
- 将年龄个性化模型的性能与七种常见的全组重新抽样技术进行了比较.
主要成果:
- 建议的年龄个性化模型在年轻成年人年龄组 (30-44岁) 中,在糖尿病类的回忆率上得到了26%至40%的持续改进.
- 这种技术在年轻人中糖尿病回忆方面,在7种广泛使用的重新抽样方法中,表现至少为36%.
- 特征重要性分析显示,年龄在原始模型中的一个重要因素,在年龄个性化模型中得到了适当的上下文化,从而提高了平衡精度 (7-12%).
结论:
- 针对年龄的个性化机器学习模型有效地减轻了对2型糖尿病的年轻成年人的诊断偏见.
- 与传统方法和全组重新抽样技术相比,这种方法显著提高了年轻人群中糖尿病检测的回忆力.
- 这些发现强调了需要量身定制的ML解决方案,以解决疾病预测中的人口差异,并改善医疗保健公平.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
717
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
13.1K
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Insulin: Dosing Regimen and Adverse Effects
685
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
685
